Coave Therapeutics (ex Horoma is a series a startup based in France. 1 investor tracked.
Based in France, Coave Therapeutics is a startup founded in 2018. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for rare ocular and central nervous system (CNS) diseases, utilizing its proprietary ALIGATER™ platform to create targeted, safe, and effective gene therapy products.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.